SAN FRANCISCO -- For sepsis-induced hypotension, a restrictive fluid strategy with earlier vasopressor use didn't impact mortality compared with liberal fluids, the CLOVERS trial showed. The ...
Intravenous fluids and vasopressor agents are commonly used in early resuscitation of patients with sepsis, but comparative data for prioritizing their delivery are limited. In an unblinded ...
Peripheral vasoactive drugs show a low rate of complications when delivered by a well-trained and experienced service, confirms the SPOTLESS study. No major or minor complications with morbidity were ...
Sepsis is the body’s extreme reaction to an infection. It causes 11 million deaths annually and is a global health priority affecting 55 million patients worldwide annually. Treatment for sepsis ...
Mild hyponatremia in children visiting pediatric emergency departments (PEDs) is associated with higher rates of vasopressor use, ward and pediatric intensive care unit (PICU) admissions, and ...
DALLAS, Nov. 6, 2022 — The immediate use of veno-arterial mechanical circulatory extracorporeal membrane oxygenation (ECMO) devices to support adults with rapidly deteriorating or severe cardiogenic ...
Istaroxime was added to currently available inotropes and vasopressors in the study - no new safety signals were identified and physiological improvements were consistent with istaroxime responses in ...
Early use of ECMO devices to support adults with cardiogenic shock did not improve clinical outcomes
The immediate use of veno-arterial mechanical circulatory extracorporeal membrane oxygenation (ECMO) devices to support adults with rapidly deteriorating or severe cardiogenic shock was feasible but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback